In 2021, Institut Curie start-ups raised 140.6 million euros. This impressive amount reaffirms Institut Curie's unique position as a key player in French innovation, driven by one ambition: to transform research into concrete applications for patients.
Visual inspection is the most common technique used for the maintenance of civil engineering structures like bridges. While it does offer the advantage of being non-destructive, visual inspection also depends on inspectors who interpret photographs and write up inspection reports—which then become the main source of information used by the operators of these structures to optimise their maintenance plans. SOCOTEC leads the project called SOFIA in partnership with Carnot CEA LIST Insitute to develop a groundbreaking inspection tool that will bring the power of artificial intelligence to machine vision. Together in a consortium with CEA LIST, SOFIA won a French call launched by CEREMA on “connected bridges”.
The two organizations will share a joint roadmap to create long-term disruptive technologies in France and Europe. The first scientific and technological areas of focus include virtual twin experiences in health and cybersecurity. The alliance aims to support French and European ecosystems in these domains and the digital trust dynamic. Alliance builds on the existing 20-year collaboration between the two organizations that has already helped advance science and innovation in digital technology.
AVATAR MEDICAL, spin-off from Carnot Curie Cancer Institute and Carnot Pasteur MS Institute, announces a €1.2 million fundraising for its virtual reality solution that aims to radically change the way surgeons access, interpret and act on clinical data contained in medical images.
Today, medical students can practice surgical procedures on "digital doubles" of patients in a safe, controlled virtual reality environment. When combined with haptic interfaces (from the Greek word haptomai, meaning "touch"), these tools can rapidly bring interns up to speed for clinical examinations on real patients.
COVID-19: Institut Imagine and Cerba HealthCare are partnering to test for patients likely to develop severe symptoms
In 2020, researchers at Inserm, Université de Paris, and Assistance Publique–Hôpitaux de Paris (AP-HP), in collaboration with the university hospital organisation Institut Imagine (Hôpital Necker-Enfants malades AP-HP), which has been granted “Institut Carnot” certification through The Rockefeller University and the Howard Hughes Medical Institute in New York, identified the leading genetic and immunological causes responsible for at least 15% of serious forms of Covid-19. Today, this same French and American team, jointly lead by Jean-Laurent Casanova and Laurent Abel* at the Institut Imagine and The Rockefeller University, is joining forces with Cerba HealthCare, a leading stakeholder in medical diagnostics, to transform these discoveries into clinical applications and screen individuals who are more likely to develop a severe form of the disease and tailor their treatment accordingly.
IQVIA, world leader in the healthcare data market, and the CALYM Carnot Institute, Consortium for the Acceleration of Innovation and its Transfer in the Lymphoma Field, have entered into a strategic partnership around a hematology database, the HemSys software. As part of this exclusive partnership, IQVIA is making its expertise and network available to CALYM, in the valorization of health data for research purposes and access to the market for therapeutic innovations.
For this 100% digital version, the CEA is supporting 3 spin off start-ups from its laboratories that have developed technological solutions in response to three major societal challenges:
The energy transition, with Wise-Integration, which will present the world's smallest charger for electric bicycles,
The digital transition with Alkalee, which has developed a software suite equipped to bring agility and openness to the vehicles of tomorrow,
- And the health of the future, with iUMTEK for rapid quantitative and qualitative diagnosis of air pollution
Institut Curie (Curie Cancer Carnot Institute) & Google initiate a collaboration using artificial intelligence (AI) for the analysis of complex data
Institut Curie (Curie Cancer Carnot Institute) and Google initiate a joint artificial intelligence research program to develop and implement deep learning methods for the analysis of complex single-cell transcriptomic and epigenetics data. Obtained from mouse samples and cell lines, these valuable data sets will be used to develop new deep-learning algorithms. In the long term, this research project could help characterize the heterogeneity of tumors and predict resistance to treatment.
Ibex Medical Analytics & Institut Curie (Curie Cancer Carnot Institute) partner to improve AI-powered breast cancer detection
Institut Curie (Curie Cancer Carnot Insitute) and Ibex Medical Analytics, a pioneer in artificial intelligence based cancer diagnostics, announce a research partnership aimed at improving diagnosis of breast cancer with Artificial Intelligence